KLP Kapitalforvaltning’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.65M Hold
37,000
– – 0.01% 846
2026
Q2
$2.93M Buy
37,000
+3,100
+9% +$233K 0.01% 601
2026
Q1
$2.55M Buy
33,900
+400
+1% +$31.6K 0.01% 624
2025
Q4
$2.65M Buy
33,500
+2,000
+6% +$151K 0.01% 608
2025
Q3
$2.06M Hold
31,500
– – 0.01% 691
2025
Q2
$1.24M Buy
31,500
+4,100
+15% +$134K 0.01% 865
2025
Q1
$827K Sell
27,400
-1,800
-6% -$58.9K ﹤0.01% 1030
2024
Q4
$1.02M Buy
+29,200
New +$1.09M ﹤0.01% 987

Other funds holding IONS

KLP Kapitalforvaltning's IONS Position: Q3 2026 in Review

KLP Kapitalforvaltning held its Ionis Pharmaceuticals (IONS) position steady in Q3 2026 at 37,000 shares worth $1.65M. The position accounts for 0.01% of the portfolio, ranked #846.

KLP Kapitalforvaltning first reported a position in IONS in Q4 2024 and has held it in 8 quarters since. The position peaked at $2.93M in Q2 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • KLP Kapitalforvaltning held 37,000 shares of Ionis Pharmaceuticals worth $1.65M as of Q3 2026.
  • KLP Kapitalforvaltning left its Ionis Pharmaceuticals share count unchanged in Q3 2026.
  • Ionis Pharmaceuticals made up 0.01% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #846 holding.
  • KLP Kapitalforvaltning first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • KLP Kapitalforvaltning's Ionis Pharmaceuticals position peaked at $2.93M in Q2 2026.
  • 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.